Vulvodynia Treatment Industry Charts Course for a Remarkable US$ 8 Billion Valuation by 2028-FMI Report

The vulvodynia treatment industry is currently worth US$ 5.6 billion, and it is anticipated to reach US$ 8 billion by 2028, growing at an impressive CAGR of 6.3% from 2022 to 2028. In order to cater to the need of the growing number of patients, companies are looking out for treatments and drugs that can subside …

Global Dialysis Equipment Industry is expected to experience remarkable growth, reaching US$ 29.93 Billion by 2033, according to FMI

From 2023 to 2033, sales of global dialysis equipment industry share are anticipated to increase at a CAGR of 4.8%. According to FMI, the size of the global dialysis equipment market could exceed US$ 18.73 billion in 2023 and reach US$ 29.93 billion by 2033. End-stage renal diseases (ESRD) are quite common in the elderly …

Zika Virus Testing Industry Navigating the Growth Trajectory Towards a US$ 6.8 Million Milestone by 2033-FMI Report

The zika virus testing industry stands as a crucial bulwark in the defense against a formidable global health threat. Zika virus, transmitted primarily through mosquito bites, gained widespread attention due to its potential to cause serious birth defects and neurological complications. Testing for Zika virus infection is paramount for identifying cases, implementing timely interventions, and preventing …

Global Muscle Stimulation Devices Industry to exhibit a 3.3% CAGR, potentially reaching a valuation of US$ 996.7 Million by 2033 | FMI

The global muscle stimulation devices industry size is expected to be worth US$ 720.4 million in 2023. The industry is expected to be worth US$ 996.7 million by 2033 securing a CAGR of 3.3% from 2023 to 2033. Muscle stimulation devices are in high demand due to growing awareness of health and an increase in …

Rare Neurological Disease Treatment Industry Set to Skyrocket, Projected to Reach a US$ 19.795 Billion Horizon by 2032-FMI Report

The majority of rare diseases currently have no or few effective diagnostic and treatment procedures, which can be attributed in part to a lack of funding for research on rare disease pathogenesis and a lack of representative patients. rare neurological disease treatment industry are one of the most common types of rare diseases, with ineffective diagnoses …

Global Gynaecological Examination Chair Industry is projected to experience significant growth, reaching US$ 852.3 Million by 2028, according to FMI

The global gynaecological examination chairs industry trends is estimated to grow from its 2021 estimate of US$ 531.6 million to US$ 852.3 million by 2028 reflecting a cumulative CAGR of 6.9% over the forecast period (2022-2028). Gynaecological examination chairs will make up around 38% of the whole medical examination chair market in 2021, when it …

Rare Inflammatory Disease Treatment Industry Skyrockets to a Whopping US$ 17,335.8 Million by 2028-FMI Report

The rare inflammatory diseases treatment industry was valued at US$12,664 million in 2021; analysts predict it will grow at a rate of 4.6% between 2022 and 2028 to reach US$17,335.8 million. The rare inflammatory disease treatment market has witnessed remarkable growth and innovation in recent years, owing to increasing awareness and advancements in medical research. Rare …

Surface Plasmon Resonance Industry Anticipates a Radiant Growth to Reach US$ 1807.7 Million by 2032

Surface plasmon resonance industry growth is anticipated, rising from US$ 910.4 million in 2022 to US$ 1807.7 million in 2032. The market is expected to grow at a CAGR of 7.1% over the course of the forecast period, according to FMI. Increasing adoption of label-free detection techniques over labelled detection techniques is due to their cost-effective …

Global Ultrasound Conductivity Gels Industry anticipates remarkable growth, targeting a US$ 439.1 Million valuation by 2028 | FMI

The global ultrasound conductivity gels industry growth is anticipated to reach US$ 439.1 million by 2028 from an estimated US$ 278.9 million in 2022, expanding at a CAGR of 7.9% over the forecast period (2022-2028). Development of conductive gel platforms for engineering materials with superior biocompatibility, variable functionalization, and changeable mechanical strength is necessary for …

Global Neurological Biomarkers Industry might hit a monumental US$ 12.5 Billion by 2033 | FMI

The global neurological biomarkers industry demand is predicted to grow quickly over the course of the forecast period, at a CAGR of 4.6%. In 2023, it is anticipated that the market for neurological biomarkers would be worth US$ 8 billion. The market for neurological biomarkers is predicted to reach a peak of US$ 12.5 billion …